Your browser doesn't support javascript.
loading
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion.
Armstrong, Heather K; Gillis, Joanna L; Johnson, Ian R D; Nassar, Zeyad D; Moldovan, Max; Levrier, Claire; Sadowski, Martin C; Chin, Mei Yieng; Tomlinson Guns, Emma S; Tarulli, Gerard; Lynn, David J; Brooks, Douglas A; Selth, Luke A; Centenera, Margaret M; Butler, Lisa M.
Afiliação
  • Armstrong HK; Adelaide Medical School and Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Gillis JL; South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Johnson IRD; Adelaide Medical School and Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Nassar ZD; South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Moldovan M; Mechanisms in Cell Biology and Disease Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, 5001, Australia.
  • Levrier C; Adelaide Medical School and Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Sadowski MC; South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Chin MY; South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
  • Tomlinson Guns ES; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia.
  • Tarulli G; Australian Prostate Cancer Research Centre - Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia.
  • Lynn DJ; The Vancouver Prostate Centre at Vancouver General Hospital, and Department of Urologic Sciences, University of British Columbia, Vancouver, B.C, Canada.
  • Brooks DA; The Vancouver Prostate Centre at Vancouver General Hospital, and Department of Urologic Sciences, University of British Columbia, Vancouver, B.C, Canada.
  • Selth LA; Adelaide Medical School and Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Centenera MM; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.
  • Butler LM; South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.
Sci Rep ; 8(1): 2090, 2018 02 01.
Article em En | MEDLINE | ID: mdl-29391407
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fibronectinas / Via Secretória Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fibronectinas / Via Secretória Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália